Piermont Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-7,100
| Closed | -$425K | – | 202 |
|
|
2018
Q2 | $425K | Sell |
7,100
-1,270
| -15% | -$76K | 0.13% | 171 |
|
|
2018
Q1 | $383K | Sell |
8,370
-1,390
| -14% | -$63.6K | 0.13% | 198 |
|
|
2017
Q4 | $389K | Sell |
9,760
-530
| -5% | -$21.1K | 0.13% | 200 |
|
|
2017
Q3 | $412K | Sell |
10,290
-10,924
| -51% | -$437K | 0.14% | 190 |
|
|
2017
Q2 | $914K | Sell |
21,214
-9,927
| -32% | -$428K | 0.26% | 153 |
|
|
2017
Q1 | $975K | Hold |
31,141
| – | – | 0.23% | 158 |
|
|
2016
Q4 | $786K | Sell |
31,141
-600
| -2% | -$15.1K | 0.18% | 181 |
|
|
2016
Q3 | $785K | Sell |
31,741
-36,140
| -53% | -$894K | 0.19% | 186 |
|
|
2016
Q2 | $1.38M | Buy |
67,881
+32,756
| +93% | +$667K | 0.36% | 103 |
|
|
2016
Q1 | $536K | Buy |
35,125
+1,335
| +4% | +$20.4K | 0.17% | 136 |
|
|
2015
Q4 | $454K | Sell |
33,790
-2,270
| -6% | -$30.5K | 0.14% | 155 |
|
|
2015
Q3 | $506K | Sell |
36,060
-24,930
| -41% | -$350K | 0.17% | 129 |
|
|
2015
Q2 | $1.04M | Hold |
60,990
| – | – | 0.31% | 102 |
|
|
2015
Q1 | $737K | Buy |
60,990
+20,610
| +51% | +$249K | 0.22% | 111 |
|
|
2014
Q4 | $335K | Buy |
+40,380
| New | +$335K | 0.12% | 162 |
|